This Solicitation opportunity from Department Of Defense was posted on July 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SCOPOLAMINE TRANSDERMA

Closed

SPE2DP-26-T-4267Federal

Submission Closed07/29/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

Lidocaine Hydrochloride Jelly Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Orange Flavored Electrolyte Oral Hydration Powder

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5007

Solicitation SPE2DP-26-T-5007 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The requirement consists of three packages of oral pain relievers, each containing 16 lozenges with 15mg of Benzocaine and 2.6mg of Menthol, identified by NSN 6505-01-708-1449. The items must be stored between 20-25 degrees Celsius and protected from humidity, with a non-extendable shelf life of 36 months. Delivery is required within 20 days after order, with a required delivery date of September 14, 2026, shipped FOB Destination to Prince Sultan Air Base in Saudi Arabia. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, utilizing sealed unit containers to prevent damage. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contractor is required to use the Wide Area WorkFlow system for electronic invoicing and receiving reports. This procurement is governed by NAICS 325411 and includes standard FAR and DFARS clauses regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-5016

This contract is for the procurement of fruit punch flavored glucose gel, provided in 1.1oz squeezable pouches and sold in packages of six. The product is fat-free, gluten-free, and designed for energy boosting, with a non-extendable shelf life of 36 months. Storage requirements specify room temperature and prohibit refrigeration, freezing, or exposure to excessive heat and moisture. The order consists of four packages to be delivered to the Naval Health Clinic Quantico in Virginia within 20 days. Compliance is required for DLA packaging and palletization standards, as well as Medical Marking Standard No. 1. The shipment must be sent via traceable means, and the contract adheres to specific technical and quality requirements set forth in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-26-T-4991

Solicitation SPE2DP-26-T-4991, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotes for orange flavored electrolyte oral rehydration salts. The requirement consists of four packages of 21 gram packets, provided in quantities of 100 per unit, under NSN 6505-01-687-1441. The delivery is specified as FOB Destination with a required delivery date of September 11, 2026, and a delivery window of 20 days after the order. Inspection and acceptance will occur at the destination, specifically for shipment to the USS Tucson SSN 770. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4997

Solicitation SPE2DP-26-T-4997 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Lidocaine Hydrochloride 2% mucosal jelly. The requirement consists of two boxes of sterile topical anesthetic, with each box containing ten 11ml single-use prefilled plastic syringes, each providing 220 mg of the substance. The items are identified by NSN 6505-01-707-4169 and are subject to a non-extendable shelf-life requirement of 36 months. Delivery is required within 20 days after the order, with an original required delivery date of May 1, 2025. The shipping terms are FOB Destination, with primary delivery to Camp Pendleton, California, and a bulk break point in Palmerston, Australia. The contractor must adhere to strict packaging and marking standards, including MIL-STD-2073-1E, RP001 for palletization, and Medical Marking Standard No. 1. All items must be packaged in sealed unit containers to prevent damage and labeled according to the Hazard Communication Standard where applicable. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information. Quotations for this requirement were due by September 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPONSE

Solicitation # SPE2DS-26-T-421W

Solicitation SPE2DS-26-T-421W is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of eight Card Casualty Response Documentation Tools, identified by NSN 6515-01-575-2772. These tools are designed for first responders to document initial casualty treatment and consist of 6.5 by 4.25 inch card stock wrapped in clear plastic, featuring a grommet, a 14-inch cable tie for patient attachment, and a unique individual bar code identifier. The items must be delivered to Fort Bragg, North Carolina, within 20 days after receipt of the order, with a required delivery date of September 14, 2026. The contract mandates strict adherence to DLA Master List of Technical and Quality Requirements, ASTM D3951 for packaging, and MIL-STD-129 and Medical Marking Standard No. 1 for labeling. Bidders are required to specify the source and part number being supplied and must provide a complete data package for any alternate parts offered. Evaluation may include a HUBZone price preference. Compliance with the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information is required. Invoicing and payment must be processed through the Wide Area WorkFlow system, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4950

Contract SPE2DP-26-T-4950 is a solicitation issued by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of Psyllium Hydrophilic Mucilloid with sugar orange flavor. The item is supplied in 12 gram packets, with each packet containing 25 mg of potassium and 5 mg of sodium, provided in packages of 30. The requirement is for one package under NSN 6505017193181, with a specified shelf life of 24 months that is non-extendable. The product is regulated by the FDA and must be marked according to Medical Marking Standard No. 1. The contract specifies delivery to the USS Roosevelt DDG 80 within 20 days of order. All packaging and palletization must adhere to DLA packaging requirements for procurement and MIL-STD-2073-1E, ensuring items are in sealed unit containers to prevent damage. Bidders are required to specify the source and part number, with the reference part number listed as NDC37000-0740-87 from Procter and Gamble Distributing LLC. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4946

Contract SPE2DP-26-T-4946 is a solicitation issued by the Department of Defense, specifically the DLA Troop Support Medical Supply Chain Pharm FSA, for the procurement of Ondansetron Injection, USP. The requirement is for a 2 mg/ml concentration in 2ml single dose vials, with a package size of 25 units per package. The item must have a non-extendable shelf life of 24 months and be stored between 2 and 25 degrees Celsius while being protected from light. Approved part numbers include those from Hikma Pharmaceuticals USA Inc, Pfizer Inc, and American Pharmaceutical Partners. The contract specifies a quantity of one package under NSN 6505015786170, with a required delivery date of July 2, 2025, and a delivery window of 20 days after order. Shipping is FOB destination to the 5th BN 14th Marines in Seal Beach, California, and must be sent via traceable means rather than parcel post. Packaging must adhere to commercial standards, Medical Marking Standard No. 1, and DLA packaging requirements for procurement. The solicitation falls under NAICS code 325411 and requires compliance with the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

High Char Yield Polymer Resin Development

NASA SBIR/STTR Program

POSTED

DEADLINE

Supplier of Raw Active Pharmaceutical Ingredient (API) – DiazepamThe Defense Logistics Agency, under the Department of Defense, has established a subcontract for the supply of bulk Diazepam Active Pharmaceutical Ingredient. The material must adhere to USP standards to ensure suitability for the formulation of 5 mg tablets. The supplier is required to provide a Certificate of Analysis and necessary regulatory support to maintain compliance. This procurement falls under NAICS code 325411 and was posted on August 11, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Active Pharmaceutical Ingredient (API) – Promethazine HydrochlorideThe contract pertains to the supply of USP-grade promethazine hydrochloride active pharmaceutical ingredient for use in the final formulation of a pharmaceutical product, specifically under a subcontract arrangement. The procurement is managed by the Defense Logistics Agency within the Department of Defense, with the NAICS code 325411 indicating classification under pharmaceutical and biological product manufacturing. Although the solicitation number and specific point of contact are not provided, the posting date is August 9, 2026, and the performance location details are unspecified. The API must meet United States Pharmacopeia standards to ensure quality and compliance with regulatory requirements for drug manufacturing. The contract reference number SPE2DX25D8022 and delivery identifier SPE2D926F8075 are linked through the DIBBS system, facilitating tracking and award administration for the supplier.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

The contract pertains to the procurement of the Scopolamine Transdermal System, a medical product delivering 1.5 mg of scopolamine over a three-day period, with each box containing ten transdermal pouches. The item is identified by NSN 6505-01-692-5042 and NDC 10019-0553-03, manufactured by Baxter Healthcare Corporation. Delivery is required within five days after order placement to Fort Bragg, North Carolina, under FOB destination terms, with the government assuming responsibility at the point of delivery. The entire supply run comprises six boxes, with no tolerance for quantity variance. Strict storage conditions mandate controlled room temperature between 68°F and 77°F (20°C to 25°C), with pouches required to remain upright and never bent or rolled. The product carries a non-extendable shelf life of 36 months, classified as a Type I (Code Q) item under DLA standards. Packaging must conform to commercial specifications as defined in the procurement document, with each unit sealed in a protective container and shipped in commercial exterior containers that ensure safe, cost-effective delivery via common carrier. All marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and follow the latest DLA guidelines for traceability and logistics compliance. The packaging data must comply with MIL-STD-2073-1E, with specific preservation and unit container codes applied, and palletization must meet RP001 requirements. Shipment must be sent via the fastest traceable means, excluding parcel post. The contract includes a range of federal acquisition regulatory clauses governing safety, security, and compliance. Hazardous material requirements mandate adherence to OSHA’s Hazard Communication Standard and the submission of Safety Data Sheets prior to award, with labeling and notification protocols for radioactive materials also enforced. Contractors must provide their Unique Entity ID and CAGE code if supplying covered defense telecommunications equipment or services. Electronic invoicing through Wide Area WorkFlow is mandatory, and compliance with cybersecurity standards including NIST SP 800-171 and safeguarding of covered defense information is required. The contract incorporates clauses related to combating trafficking in persons, employment eligibility verification, sustainable products, and accelerated small business payments. Pricing information, though partially fragmented, indicates a total estimated value of approximately $1,200 for the base quantity, with potential for additional line items under

General Info

6 boxes of Scopolamine patches, NSN 6505-01-692-5042, to Fort Bragg by July 27, 2026, FOB destination, proper packaging and storage.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4267 Medical Supply Chain Pharm FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 23

Solicitation

Response DeadlineJul 29

Deadline has passed

Submission Closed

07/29/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

Lawrence Garnett

contact@example.gov

+1 (555) 000-0000

Full Description

SCOPOLAMINE TRANSDERMAL SYSTEM
SCOPOLAMINE TRANSDERMAL SYSTEM
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TRANSDERM-SCOPOLAMINE 1.5MG (1MG/3D) 10 EACH PER BOX.
U/I (1) BOX
SCOPOLAMINE TRANSDERMAL SYSTEM 1.5MG RELEASED OVER A 3 DAY PERIOD: Store at controlled room temperature between 68 F to 77 F (20 C to 25 C). Store pouch(es) in an upright position. Do not bend or roll pouch(es).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SPE2DP-26-T-4267
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC10019-0553-03
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017598138 0001 BX 6.000
NSN/MATERIAL:6505016925042
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
SPE2DP-26-T-4267
SECTION B
PR: 7017598138 PRLI: 0001 CONT’D
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262030109
RDD: 218
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/27/2026
SPE2DP-26-T-4267 NSN/Part Number: 6505-01-692-5042 Quantity: 6 BX Purchase Request: 7017598138QTY: 6 Delivery: 5 days ADO